Cybin (HELP) Net Equity Issued and Repurchased (2020 - 2025)

Cybin's (HELP) quarterly Net Equity Issued and Repurchased came in at $135.9 million in Q4 2025, up 1241.35% on a QoQ basis from $10.1 million in Q2 2025.

Cybin (HELP) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

Cybin (HELP) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $135.9 million in Q4 2025.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $135.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $175.2 million (changed N/A YoY) and the FY2022 annual result came in at $42.9 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased improved to $135.9 million in Q4 2025, from $10.1 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $135.9 million in Q4 2025 to a low of $2.5 million in Q4 2022.
  • A 4-year average of $27.9 million and a median of $12.7 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased jumped 4285.05% — and 2023, when it soared 1045.56%.
  • Tracing HELP's Net Equity Issued and Repurchased over 4 years: stood at $25.0 million in 2021, then plunged by 89.82% to $2.5 million in 2022, then soared by 1045.56% to $29.2 million in 2023, then soared by 365.61% to $135.9 million in 2025.
  • The last three Net Equity Issued and Repurchased figures came in at $135.9 million (Q4 2025), $10.1 million (Q2 2025), and $29.2 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Cybin 417.29 Mn 417.29 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 135.92 Mn
Dec 31, 2025 135.92 Mn
Jun 30, 2025 10.13 Mn
Jun 30, 2025 10.13 Mn
Dec 31, 2023 29.19 Mn
Dec 31, 2023 29.19 Mn
Sep 30, 2023 15.21 Mn
Sep 30, 2023 15.21 Mn
Jun 30, 2023 2.62 Mn
Jun 30, 2023 2.62 Mn
Dec 31, 2022 2.55 Mn
Dec 31, 2022 2.55 Mn
Feb 28, 2022 2.67 Mn
Feb 28, 2022 2.67 Mn
Sep 30, 2021 25.03 Mn
Sep 30, 2021 25.03 Mn
Dec 31, 2020 33.96 Mn
Dec 31, 2020 33.96 Mn
Sep 30, 2020 -598,087.67
Sep 30, 2020 -598,087.67